What is the recommended IV fluid regimen (type, rate, monitoring, and albumin use) for an adult (≥12 years) with acute viral hepatitis or decompensated chronic hepatitis, especially when ascites, hepatic encephalopathy, or pulmonary congestion are present?

IV Fluid Management in Hepatitis

Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) over normal saline for volume resuscitation in patients with acute or decompensated hepatitis requiring IV fluids, and reserve albumin for specific liver-related indications rather than routine resuscitation. 1

Fluid Type Selection

Crystalloids for Initial Resuscitation

• Balanced crystalloids (lactated Ringer's or Plasma-Lyte) are associated with reduced mortality compared to normal saline in critically ill patients, based on meta-analysis of 13 RCTs involving 35,884 patients. 1
• Normal saline should be avoided in cirrhotic patients with ascites because it aggravates sodium retention and worsens fluid accumulation. 2
• The 2024 AASLD guidance explicitly recommends balanced crystalloids for resuscitation in hypovolemia and shock states in patients with cirrhosis. 1

Albumin: Specific Indications Only

Albumin has defined roles in liver disease but should not be used as a routine resuscitation fluid. 1

Established Indications for Albumin:

• Large-volume paracentesis (>5 L): 8 g albumin per liter of ascites removed, administered after the procedure is completed. 1, 2, 3
• Spontaneous bacterial peritonitis (SBP): 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3. 1
• Hepatorenal syndrome (HRS): 1 g/kg/day (maximum 100 g/day) for 48 hours during initial volume challenge, then 20-40 g/day with vasoconstrictors. 1

Albumin in Septic Shock (Controversial):

• A 2024 RCT (308 patients with cirrhosis and sepsis-induced hypotension) showed 5% albumin achieved higher reversal of hypotension and improved 1-week survival (43.5% vs. 38.3%, p=0.03) compared to normal saline. 1
• However, a trial targeting serum albumin ≥3 g/dL in 777 hospitalized patients with decompensated cirrhosis found no benefit and significantly higher rates of pulmonary edema and fluid overload. 1
• Clinical recommendation: Consider albumin for sepsis-induced hypotension in cirrhosis, but do not target a specific albumin level—this increases pulmonary complications without improving outcomes. 1

Monitoring and Rate of Administration

Hemodynamic Targets

• Maintain mean arterial pressure (MAP) ≥65 mm Hg in critically ill patients with cirrhosis and shock, using frequent assessment of end-organ perfusion (mental status, capillary refill, urine output, lactate). 1
• Invasive arterial monitoring should be initiated as soon as practical. 1

Vasopressor Support

• Norepinephrine (0.01-0.5 μg/kg/min) is the first-line vasopressor for septic shock in patients with hepatitis and cirrhosis. 1
• Vasopressors should be started peripherally rather than delaying for central access. 1
• Vasopressin may be added as a second-line agent to norepinephrine. 1

Special Considerations by Clinical Scenario

Ascites Management

• Avoid routine IV fluids in stable patients with ascites—management centers on sodium restriction (<2 g/day), diuretics (spironolactone 100-400 mg/day with furosemide 40-160 mg/day in a 100:40 ratio), and therapeutic paracentesis when indicated. 2, 4
• For large-volume paracentesis (>5 L), albumin replacement at 8 g/L is mandatory to prevent post-paracentesis circulatory dysfunction, which occurs in 21% of patients without albumin versus 0% with albumin. 2, 3, 4

Hepatic Encephalopathy

• Fluid management does not differ based on encephalopathy presence, but avoid medications that worsen encephalopathy (benzodiazepines, opioids). 1
• Lactulose and rifaximin are recommended for encephalopathy treatment but do not alter fluid strategy. 1

Pulmonary Congestion Risk

• In patients at risk for volume overload (cirrhotic cardiomyopathy, renal dysfunction), use conservative fluid boluses of 250-500 mL with reassessment after each bolus. 1
• Albumin infusion should occur over 1-2 hours to avoid volume overload, particularly when using 20% or 25% hyperoncotic solutions. 2, 3
• Avoid targeting specific serum albumin levels (e.g., ≥3 g/dL) as this strategy increases pulmonary edema without clinical benefit. 1

Acute Kidney Injury (AKI) in Hepatitis

• After withdrawing diuretics and treating precipitating factors (infection), administer albumin 1 g/kg (maximum 100 g/day) for 48 hours to distinguish hepatorenal syndrome from other causes of AKI. 1
• Isotonic crystalloids are preferred over colloids for initial volume expansion in AKI, with avoidance of starch-containing fluids. 1

Medications to Avoid

The following medications worsen fluid retention and should be discontinued in patients with hepatitis and ascites: 2

• NSAIDs (indomethacin, ibuprofen, aspirin, sulindac): cause acute renal failure, hyponatremia, and diuretic resistance
• ACE inhibitors and angiotensin-II receptor blockers: cause arterial hypotension and renal failure
• α₁-adrenergic blockers (prazosin): impair renal sodium retention
• Aminoglycosides: increase risk of renal failure (reserve for infections not treatable with other agents)

Common Pitfalls

• Do not use normal saline in cirrhotic patients—it worsens sodium retention and ascites. 2
• Do not administer albumin during paracentesis—give it after the procedure is completed. 2, 3
• Do not use albumin to target a specific serum albumin level—this increases pulmonary complications. 1
• Do not withhold paracentesis due to coagulopathy—routine correction of INR or platelet count is not required even with severe coagulopathy (INR ≤8.7, platelets ≈19×10³/μL). 2
• Do not use diuretics to prevent or treat AKI—they are only indicated for volume overload management. 1